ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO1095

Epidemiology and Clinical Outcomes of Staphylococcus aureus Bacteraemias in Haemodialysis Patients; 12-Year Single-Centre Experience

Session Information

  • Vascular Access - II
    November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 704 Dialysis: Vascular Access

Authors

  • Hurst, Jonathan William, Epsom & St. Helier University Hospitals NHS Trust, Surrey, United Kingdom
  • Stanley, Moira, Epsom & St. Helier University Hospitals NHS Trust, Surrey, United Kingdom
  • Rangaiah, Jayakeerthi, Epsom & St. Helier University Hospitals NHS Trust, Surrey, United Kingdom
  • Makanjuola, David, Epsom & St. Helier University Hospitals NHS Trust, Surrey, United Kingdom
Background

Patients on haemodialysis are at risk of access associated infections. The risk is greater in patients dialysed through lines, than those dialysing via arteriovenous fistulae (AVF) or grafts (AVG). Studies have shown that the most commonly implicated organism is Staphylococcus aureus (SA), which has a tendency to cause metastatic infections e.g endocarditis, osteomyelitis. We decided to look at the incidence and clinical outcomes in haemodialysis (HD) patients with SA bacteraemia in patients at our centre over the last 12 years.

Methods

Data were collected from the hospital’s microbiology database of all the confirmed bacteraemias in HD patients between 2007 and 2018. We looked at the demography, type of dialysis access, and the outcomes following the bacteraemias.

Results

There were 261 bacteraemias in 1361 patients who had a cumulative total of 32,000 dialysis episodes over the 12 year period. Of the patients with bacteraemias, 164 (62.8%) were male. The median age was 67 years (range 18-96). The dialysis access at the time of the bacteraemia was as follows: AVF/AVG 57(22%), dual access - AVF or graft + line - 50 (20%), dialysis line 147 (56%), not documented 7 (3%). The blood cultures grew methicillin sensitive SA (MSSA) in 71% and methicillin resistant SA in 29% of cases. 204 (77%) cases occurred in patients dialysing through lines. Details about complications were available in 199 patients and are shown in Table 1.

Conclusion

Our data show that the bacteraemias and complications were most common in patients dialysing with lines, and emphasise the importance of trying to achieve dialysis through AVFs or grafts as soon as is possible.

Table 1 – Complications following SA bacteraemias
COMPLICATIONNUMBER (%)LINESAVF/GRAFTS
Discitis541
Endocarditis1394
Septic arthritis431
Death26215
Total4837 (77%)11 (23%)